379
Participants
Start Date
December 16, 2013
Primary Completion Date
December 23, 2014
Study Completion Date
December 23, 2014
Epanova
Epanova will be provided in 1 g polyacrylate-coated soft gel capsules. Two capsules will be taken once per day, without regard to meals, for 12 weeks. At clinic visits, study drug will be administered at the clinic after fasting blood draws are complete.
Olive Oil
Olive oil will be provided in 1 g polyacrylate-coated soft gel capsules. Two capsules will be taken once per day, without regard to meals, for 12 weeks. At clinic visits, study drug will be administered at the clinic after fasting blood draws are complete.
Research Site, Budapest
Research Site, Herlev
Research Site, Gentofte Municipality
Research Site, Szikszó
Research Site, Sátoraljaújhely
Research Site, Debrecen
Research Site, Debrecen
Research Site, Baja
Research Site, Esbjerg
Research Site, Székesfehérvár
Research Site, Balatonfüred
Research Site, Viborg
Research Site, Philadelphia
Research Site, Orangeburg
Research Site, St. Petersburg
Research Site, Bristol
Research Site, Louisville
Research Site, Columbus
Research Site, Lyndhurst
Research Site, Cincinnati
Research Site, Cincinnati
Research Site, Kettering
Research Site, Hradec Kralova
Research Site, Addison
Research Site, Oklahoma City
Research Site, Zlín
Research Site, Houston
Research Site, Katy
Research Site, Los Angeles
Research Site, Moscow
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Yekaterinburg
Research Site, Tomsk
Research Site, Kemerovo
Research Site, Barnaul
Research Site, Chicoutimi
Research Site, Trutnov
Research Site, Alkmaar
Research Site, Amsterdam
Lead Sponsor
AstraZeneca
INDUSTRY